HDL function | Control (n = 110) | ACS baseline (n = 150) | ACS follow-up (n = 100) |
---|---|---|---|
Cholesterol efflux capacity (A.U.) | 1.02 ± 0.16 | 0.88 ± 0.15*** | 0.94 ± 0.17### |
Male | 1.04 ± 0.16 | 0.9 ± 0.14* | 0.99 ± 0.19### |
Female | 1.0 ± 0.14 | 0.87 ± 0.15* | 0.93 ± 0.19 |
Paraoxonase activity (U/ml) | 105.1 ± 56.4 | 69.1 ± 38.8*** | 81.1 ± 45.5### |
Male | 107.1 ± 56.2 | 69.5 ± 40.0* | 82.4 ± 46.5### |
Female | 101.9 ± 57.1 | 65.5 ± 29.1* | 72.1 ± 37.5 |
Arylesterase activity (U/ml) | 112.0 ± 36.3 | 82.1 ± 27.9*** | 101.8 ± 30.6### |
Male | 113.8 ± 38.8 | 81.0 ± 28.1* | 100.4 ± 31.0### |
Female | 109.4 ± 32.7 | 90.2 ± 26.6* | 111.8 ± 26.3### |